Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Magalashvili

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|November 27, 2020
Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online surveyAlon Kalron, Mark Dolev, Michal Greenberg-Abrahami, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 23, 2023
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysisShay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, et al.
Journal of Neuroengineering and Rehabilitation|December 20, 2021
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-aShay Menascu, Roy Aloni, Mark Dolev, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 5, 2024
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational studyShay Menascu, Simona Halusková, Amir Pollak, et al.
Archives of Neurology|October 13, 2004
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trialAnat Achiron, Irena Kishner, Ida Sarova-Pinhas, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Autoimmunity Reviews|October 15, 2018
Polymerase-1 pathway activation in acute multiple sclerosis relapseAnat Achiron, Rina Zilkha-Falb, Anna Feldman, et al.
Brain Communications|January 9, 2025
Machine learning-based prediction of disease progression in primary progressive multiple sclerosisMichael Gurevich, Rina Zilkha-Falb, Jia Sherman, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Multiple Sclerosis and Related Disorders|March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumabAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|November 27, 2020
Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online surveyAlon Kalron, Mark Dolev, Michal Greenberg-Abrahami, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 23, 2023
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysisShay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, et al.
Journal of Neuroengineering and Rehabilitation|December 20, 2021
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-aShay Menascu, Roy Aloni, Mark Dolev, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 5, 2024
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational studyShay Menascu, Simona Halusková, Amir Pollak, et al.
Archives of Neurology|October 13, 2004
Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trialAnat Achiron, Irena Kishner, Ida Sarova-Pinhas, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Autoimmunity Reviews|October 15, 2018
Polymerase-1 pathway activation in acute multiple sclerosis relapseAnat Achiron, Rina Zilkha-Falb, Anna Feldman, et al.
Brain Communications|January 9, 2025
Machine learning-based prediction of disease progression in primary progressive multiple sclerosisMichael Gurevich, Rina Zilkha-Falb, Jia Sherman, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Multiple Sclerosis and Related Disorders|March 18, 2023
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumabAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Pageof 4